The guideline 'Recurrent miscarriage' (first revision) of the Dutch Society for Obstetrics and Gynaecology [6]

Autor: Van Den Boogaard, E., Goddijn, M., Steegers, E. A.P., Erwich, J. J.H.M., Macklon, N. S., Land, J. A., Ankum, W. M.
Přispěvatelé: Graduate School, Amsterdam institute for Infection and Immunity, Other Research, Center for Reproductive Medicine, Amsterdam Reproduction & Development, Obstetrics and Gynaecology, Amsterdam Reproduction & Development (AR&D)
Jazyk: Dutch; Flemish
Rok vydání: 2008
Zdroj: Nederlands tijdschrift voor geneeskunde, 152(45), 2481-2482. Bohn Stafleu van Loghum
Goddijn, M, Van Den Boogaard, E, Steegers, E A P, Erwich, J J H M, Macklon, N S, Land, J A & Ankum, W M 2008, ' Richtlijn 'Herhaalde miskraam' (eerste herziening) van de Nederlandse Vereniging voor Obstetrie en Gynaecologie ', Nederlands Tijdschrift voor Geneeskunde, vol. 152, no. 30, pp. 1665-1670 .
Nederlands tijdschrift voor geneeskunde, 152(30), 1665-1670. Bohn Stafleu van Loghum
Van Den Boogaard, E, Goddijn, M, Steegers, E A P, Erwich, J J H M, Macklon, N S, Land, J A & Ankum, W M 2008, ' Richtlijn 'Herhaalde miskraam' (eerste herziening) van de Nederlandse Vereniging voor Obstetrie en Gynaecologie ', Nederlands Tijdschrift voor Geneeskunde, vol. 152, no. 45, pp. 2481-2482 .
ISSN: 0028-2162
Popis: In 2007, the Dutch Society for Obstetrics and Gynaecology issued a revised version of the 1999 guideline on recurrent miscarriage. - The new guideline was developed according to the principles of evidence-based guideline development and includes levels of evidence. - The guideline contains recommendations for effective diagnosis and treatment and explicitly mentions certain diagnostic tests and treatments that should be avoided. - After a thorough investigation of a couples' history, the type of diagnostic tests that should be offered to the couple can be determined. Patients with a low risk of having cytogenetic abnormalities or thrombophilia may be excluded from parental karyotyping and thrombophilia screening, respectively. - Women with confirmed antiphospholipid antibody syndrome should be offered anticoagulation treatment before and during subsequent pregnancies. - Effective therapy for unexplained recurrent miscarriage is lacking. However, the probability of a successful future pregnancy is high. This probability can be estimated based on the number of previous miscarriages and maternal age.
Databáze: OpenAIRE